Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis

BACKGROUND: Gastric cancer is the third leading cause of cancer-related death worldwide, for which several novel therapeutic strategies have been developed. Cisplatin (CDDP) mainly exerts its anti-gastric cancer effects; however, drug resistance limits its use. Thus, the development of drugs that ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chengwei, Li, Dongchang, Wang, Jian, Wang, Zhengguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618551/
https://www.ncbi.nlm.nih.gov/pubmed/37920505
http://dx.doi.org/10.1016/j.heliyon.2023.e21110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618551/
https://www.ncbi.nlm.nih.gov/pubmed/37920505
http://dx.doi.org/10.1016/j.heliyon.2023.e21110

Ejemplares similares